FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2106350749> ?p ?o ?g. }

• W2106350749 endingPage "8" @default.
• W2106350749 startingPage "6253" @default.
• W2106350749 abstract "Growth of the human rhabdomyosarcoma A673 cell line in nude mice is substantially reduced but not completely suppressed after systemic administration of the antihuman vascular endothelial growth factor (VEGF) monoclonal antibody (Mab) A.4.6.1. Potentially, such escape might be attributable to incomplete local penetration of the antibody because of a diffusion barrier associated with tumor growth. Alternatively, it might reflect a compensatory up-regulation of murine VEGF, produced by the stroma of the host, or of other angiogenic factor genes. To test these potential mechanisms, systemic administration of Mab A.4.6.1, was performed in conjunction with intratumoral administration of an irrelevant antibody, an antihuman VEGF Fab or mFlt(1-3)-IgG that neutralizes both human and murine VEGF. Tumor growth in the systemic-plus-intratumoral anti-VEGF group was not different from that in the systemic anti-VEGF-plus-intratumoral-control antibody group, arguing against the possibility that bioavailability is the factor that limits the antitumor efficacy of Mab A.4.6.1. However, intratumoral mFlt(l-3)-IgG administration dramatically enhanced the activity of systemic anti-VEGF Mab and resulted in complete suppression of tumor growth, which indicated that host VEGF significantly contributes to tumor growth. Systemic administration of mFlt(1-3)-IgG alone replicated these findings. Histological analysis of residual tumor tissues revealed an almost complete absence of host-derived vasculature and massive tumor-cell necrosis in the mFlt(1-3)-IgG groups. Such extensive necrotic areas were not present in the other groups. Real-time reverse transcription-PCR analysis of total RNA derived from tumor tissues indicated strong up-regulation of both human and murine VEGF as well as other genes regulated by hypoxia. Our findings emphasize the need to completely block VEGF for maximal inhibition of tumor growth." @default.
• W2106350749 created "2016-06-24" @default.
• W2106350749 creator A5008842387 @default.
• W2106350749 creator A5037270460 @default.
• W2106350749 creator A5049743619 @default.
• W2106350749 creator A5052067361 @default.
• W2106350749 creator A5078995508 @default.
• W2106350749 date "2000-11-15" @default.
• W2106350749 modified "2023-10-17" @default.
• W2106350749 title "Complete inhibition of rhabdomyosarcoma xenograft growth and neovascularization requires blockade of both tumor and host vascular endothelial growth factor." @default.
• W2106350749 cites W115154409 @default.
• W2106350749 cites W1587020653 @default.
• W2106350749 cites W1964068703 @default.
• W2106350749 cites W1969328947 @default.
• W2106350749 cites W1972242350 @default.
• W2106350749 cites W1976893749 @default.
• W2106350749 cites W1985712533 @default.
• W2106350749 cites W2000000541 @default.
• W2106350749 cites W2013141629 @default.
• W2106350749 cites W2018807343 @default.
• W2106350749 cites W2034393061 @default.
• W2106350749 cites W2036751011 @default.
• W2106350749 cites W2038894713 @default.
• W2106350749 cites W2043850275 @default.
• W2106350749 cites W2045247659 @default.
• W2106350749 cites W2056574134 @default.
• W2106350749 cites W207250171 @default.
• W2106350749 cites W2093498435 @default.
• W2106350749 cites W2096735172 @default.
• W2106350749 cites W2102140960 @default.
• W2106350749 cites W2118881364 @default.
• W2106350749 cites W2138454311 @default.
• W2106350749 cites W2154200023 @default.
• W2106350749 cites W2155127143 @default.
• W2106350749 cites W2163886094 @default.
• W2106350749 cites W2764998001 @default.
• W2106350749 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11103779" @default.
• W2106350749 hasPublicationYear "2000" @default.
• W2106350749 type Work @default.
• W2106350749 sameAs 2106350749 @default.
• W2106350749 citedByCount "68" @default.
• W2106350749 countsByYear W21063507492012 @default.
• W2106350749 countsByYear W21063507492013 @default.
• W2106350749 countsByYear W21063507492014 @default.
• W2106350749 countsByYear W21063507492015 @default.
• W2106350749 countsByYear W21063507492016 @default.
• W2106350749 countsByYear W21063507492017 @default.
• W2106350749 countsByYear W21063507492018 @default.
• W2106350749 countsByYear W21063507492019 @default.
• W2106350749 countsByYear W21063507492020 @default.
• W2106350749 countsByYear W21063507492021 @default.
• W2106350749 countsByYear W21063507492023 @default.
• W2106350749 crossrefType "journal-article" @default.
• W2106350749 hasAuthorship W2106350749A5008842387 @default.
• W2106350749 hasAuthorship W2106350749A5037270460 @default.
• W2106350749 hasAuthorship W2106350749A5049743619 @default.
• W2106350749 hasAuthorship W2106350749A5052067361 @default.
• W2106350749 hasAuthorship W2106350749A5078995508 @default.
• W2106350749 hasConcept C126322002 @default.
• W2106350749 hasConcept C142724271 @default.
• W2106350749 hasConcept C146285616 @default.
• W2106350749 hasConcept C150903083 @default.
• W2106350749 hasConcept C159654299 @default.
• W2106350749 hasConcept C167734588 @default.
• W2106350749 hasConcept C170493617 @default.
• W2106350749 hasConcept C203014093 @default.
• W2106350749 hasConcept C207001950 @default.
• W2106350749 hasConcept C25938499 @default.
• W2106350749 hasConcept C2775960820 @default.
• W2106350749 hasConcept C2777025900 @default.
• W2106350749 hasConcept C2778256501 @default.
• W2106350749 hasConcept C2778271429 @default.
• W2106350749 hasConcept C2780394083 @default.
• W2106350749 hasConcept C2780844630 @default.
• W2106350749 hasConcept C502942594 @default.
• W2106350749 hasConcept C542903549 @default.
• W2106350749 hasConcept C71924100 @default.
• W2106350749 hasConcept C86803240 @default.
• W2106350749 hasConceptScore W2106350749C126322002 @default.
• W2106350749 hasConceptScore W2106350749C142724271 @default.
• W2106350749 hasConceptScore W2106350749C146285616 @default.
• W2106350749 hasConceptScore W2106350749C150903083 @default.
• W2106350749 hasConceptScore W2106350749C159654299 @default.
• W2106350749 hasConceptScore W2106350749C167734588 @default.
• W2106350749 hasConceptScore W2106350749C170493617 @default.
• W2106350749 hasConceptScore W2106350749C203014093 @default.
• W2106350749 hasConceptScore W2106350749C207001950 @default.
• W2106350749 hasConceptScore W2106350749C25938499 @default.
• W2106350749 hasConceptScore W2106350749C2775960820 @default.
• W2106350749 hasConceptScore W2106350749C2777025900 @default.
• W2106350749 hasConceptScore W2106350749C2778256501 @default.
• W2106350749 hasConceptScore W2106350749C2778271429 @default.
• W2106350749 hasConceptScore W2106350749C2780394083 @default.
• W2106350749 hasConceptScore W2106350749C2780844630 @default.
• W2106350749 hasConceptScore W2106350749C502942594 @default.
• W2106350749 hasConceptScore W2106350749C542903549 @default.
• W2106350749 hasConceptScore W2106350749C71924100 @default.
• W2106350749 hasConceptScore W2106350749C86803240 @default.

• next